Detecting Reporting Resistance in Fastidious Bacteria - SWACM

More documents

Recommendations

Info

Qualifying Results Optional Comments “Testing performed per Dr. Jones request” “Infectious Disease consult suggested” “Testing performed using a method that is not FDA cleared for testing Abiotrophia spp. but was validated in this laboratory” Consider for All M45 organism AST reports ….following discussion with medical staff and review of request / organism / drugs / results / method Note: Will not include on all examples in this talk due to space.
Specimen: Blood Diagnosis: Endocarditis Abiotrophia spp. Should we perform AST? What method? What drugs?
Page 1 and 2: Detecting / Reporting Resistance in
Page 3 and 4: CLSI M45-A2 Guideline Abiotrophia /
Page 5 and 6: Organisms Included in CLSI M45-A2 M
Page 7 and 8: Table 17. Summary of Testing Condit
Page 9 and 10: Can we test M45-A2 organisms with a
Page 14 and 15: Abiotrophia spp. / Granulicatella s
Page 16 and 17: CLSI M45-A2 Table 1 Abiotrophia / G
Page 18 and 19: CLSI M45-A2 Table 1 Abiotrophia / G
Page 20 and 21: “S” only breakpoint Abiotrophia
Page 22 and 23: Specimen: Blood Diagnosis: Endocard
Page 24 and 25: Coryneforms and Corynebacterium spp
Page 26 and 27: Specimen: Bone marrow Diagnosis: Le
Page 28 and 29: CLSI M45-A2 Table 13 Pasteurella sp
Page 30 and 31: Why should we do -lactamase test on
Page 32 and 33: -Lactamase Testing of M45 Bugs Reco
Page 34 and 35: Specimen: Cerebrospinal fluid Diagn
Page 36 and 37: Procedure used in some labs to expe
Page 38 and 39: HACEK Group Haemophilus aphrophilus
Page 40 and 41: Specimen: Blood Diagnosis: Endocard
Page 42 and 43: Moraxella catarrhalis “If desired
Page 44 and 45: Outcomes of Single Dose Azithromyci
Page 46 and 47: Table 17. Summary of Testing Condit
Page 48 and 49: Minimum Laboratory Requirements for

Detecting Reporting Resistance in Fastidious Bacteria - SWACM

Create successful ePaper yourself

Delete template?

Save as template?